Cargando…

The (+)-Brevipolide H Displays Anticancer Activity against Human Castration-Resistant Prostate Cancer: The Role of Oxidative Stress and Akt/mTOR/p70S6K-Dependent Pathways in G1 Checkpoint Arrest and Apoptosis

Because conventional chemotherapy is not sufficiently effective against prostate cancer, various examinations have been performed to identify anticancer activity of naturally occurring components and their mechanisms of action. The (+)-brevipolide H, an α-pyrone-based natural compound, induced poten...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sheng, Yi-Hua, Leu, Wohn-Jenn, Chen, Ching-Nung, Hsu, Jui-Ling, Liu, Ying-Tung, Hsu, Lih-Ching, Hou, Duen-Ren, Guh, Jih-Hwa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355498/ https://www.ncbi.nlm.nih.gov/pubmed/32630532 http://dx.doi.org/10.3390/molecules25122929

Ejemplares similares

Para-Toluenesulfonamide Induces Anti-tumor Activity Through Akt-Dependent and -Independent mTOR/p70S6K Pathway: Roles of Lipid Raft and Cholesterol Contents
por: Hsu, Jui-Ling, et al.
Publicado: (2018)

Repurposing of nitroxoline as a potential anticancer agent against human prostate cancer – a crucial role on AMPK/mTOR signaling pathway and the interplay with Chk2 activation
por: Chang, Wei-Ling, et al.
Publicado: (2015)

Phosphodiesterase Type 5 Inhibitors Synergize Vincristine in Killing Castration-Resistant Prostate Cancer Through Amplifying Mitotic Arrest Signaling
por: Hsu, Jui-Ling, et al.
Publicado: (2020)

The Combination of a Novel GLUT1 Inhibitor and Cisplatin Synergistically Inhibits Breast Cancer Cell Growth By Enhancing the DNA Damaging Effect and Modulating the Akt/mTOR and MAPK Signaling Pathways
por: Weng, Hao-Cheng, et al.
Publicado: (2022)

Non-immunosuppressive triazole-based small molecule induces anticancer activity against human hormone-refractory prostate cancers: the role in inhibition of PI3K/AKT/mTOR and c-Myc signaling pathways
por: Leu, Wohn-Jenn, et al.
Publicado: (2016)

Chalcones Display Anti-NLRP3 Inflammasome Activity in Macrophages through Inhibition of Both Priming and Activation Steps—Structure-Activity-Relationship and Mechanism Studies
por: Leu, Wohn-Jenn, et al.
Publicado: (2020)

Extract From Plectranthus amboinicus Inhibit Maturation and Release of Interleukin 1β Through Inhibition of NF-κB Nuclear Translocation and NLRP3 Inflammasome Activation
por: Leu, Wohn-Jenn, et al.
Publicado: (2019)

Discovery of Novel Agents on Spindle Assembly Checkpoint to Sensitize Vinorelbine-Induced Mitotic Cell Death against Human Non-Small Cell Lung Cancers
por: Chang, Ya-Ching, et al.
Publicado: (2020)

Autophagic Activation and Decrease of Plasma Membrane Cholesterol Contribute to Anticancer Activities in Non-Small Cell Lung Cancer
por: Hsu, Jui-Ling, et al.
Publicado: (2021)

Mechanistic Study of Triazole Based Aminodiol Derivatives in Leukemic Cells—Crosstalk between Mitochondrial Stress-Involved Apoptosis and Autophagy
por: Chan, She-Hung, et al.
Publicado: (2020)

Reevesioside A, a Cardenolide Glycoside, Induces Anticancer Activity against Human Hormone-Refractory Prostate Cancers through Suppression of c-myc Expression and Induction of G1 Arrest of the Cell Cycle
por: Leu, Wohn-Jenn, et al.
Publicado: (2014)

Strategies for the synthesis of brevipolides
por: Kurniawan, Yudhi Dwi, et al.
Publicado: (2021)

Evaluation of the Anticancer Activity of a Bile Acid-Dihydroartemisinin Hybrid Ursodeoxycholic-Dihydroartemisinin in Hepatocellular Carcinoma Cells
por: Huang, Tzu-En, et al.
Publicado: (2020)

Epi-reevesioside F inhibits Na(+)/K(+)-ATPase, causing cytosolic acidification, Bak activation and apoptosis in glioblastoma
por: Hsu, Jui-Ling, et al.
Publicado: (2015)

Phosphodiesterase Type 5 (PDE5) Inhibitors Sensitize Topoisomerase II Inhibitors in Killing Prostate Cancer Through PDE5-Independent Impairment of HR and NHEJ DNA Repair Systems
por: Chang, Jo-Fan, et al.
Publicado: (2019)

Enantiomerically pure β-dipeptide derivative induces anticancer activity against human hormone-refractory prostate cancer through both PI3K/Akt-dependent and -independent pathways
por: Chan, Mei-Ling, et al.
Publicado: (2017)

Antileukemic Natural Product Induced Both Apoptotic and Pyroptotic Programmed Cell Death and Differentiation Effect
por: Leu, Wohn-Jenn, et al.
Publicado: (2021)

The Combination of MK-2206 and WZB117 Exerts a Synergistic Cytotoxic Effect Against Breast Cancer Cells
por: Li, Yu-Liang, et al.
Publicado: (2019)

Discovery of New Glucose Uptake Inhibitors as Potential Anticancer Agents by Non-Radioactive Cell-Based Assays
por: Hung, Hsueh-Chih, et al.
Publicado: (2022)

KUD773, a phenylthiazole derivative, displays anticancer activity in human hormone-refractory prostate cancers through inhibition of tubulin polymerization and anti-Aurora A activity
por: Yu, Chia-Chun, et al.
Publicado: (2015)

Characterization of a fluorescent glucose derivative 1-NBDG and its application in the identification of natural SGLT1/2 inhibitors
por: Kao, Ting-Yu, et al.
Publicado: (2021)

Anticancer Activity and Molecular Mechanisms of an Ursodeoxycholic Acid Methyl Ester-Dihydroartemisinin Hybrid via a Triazole Linkage in Hepatocellular Carcinoma Cells
por: Hsu, Ya-Fen, et al.
Publicado: (2023)

Angelica Sinensis promotes myotube hypertrophy through the PI3K/Akt/mTOR pathway
por: Yeh, Tzu-Shao, et al.
Publicado: (2014)

13-Acetoxysarcocrassolide induces apoptosis in human hepatocellular carcinoma cells through mitochondrial dysfunction and suppression of the PI3K/AKT/mTOR/p70S6K signalling pathway
por: Hsu, Chang-Min, et al.
Publicado: (2022)

Targeting mTOR Complex 2 in Castration-Resistant Prostate Cancer with Acquired Docetaxel Resistance
por: Huang, Yujie, et al.
Publicado: (2022)

5-methoxytryptophan protects MSCs from stress induced premature senescence by upregulating FoxO3a and mTOR
por: Chang, Tzu-Ching, et al.
Publicado: (2017)

Targeting the Axl and mTOR Pathway Synergizes Immunotherapy and Chemotherapy to Butylidenephthalide in a Recurrent GBM
por: Liu, Ching-Ann, et al.
Publicado: (2022)

mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer
por: Gao, Wei, et al.
Publicado: (2012)

PKM2 under hypoxic environment causes resistance to mTOR inhibitor in human castration resistant prostate cancer
por: Yasumizu, Yota, et al.
Publicado: (2018)

Exosomal miR‐222‐3p contributes to castration‐resistant prostate cancer by activating mTOR signaling
por: Wang, Weixi, et al.
Publicado: (2023)

Activation of the mTOR Pathway by Oxaliplatin in the Treatment of Colorectal Cancer Liver Metastasis
por: Lu, Min, et al.
Publicado: (2017)

Immunofluorescence can assess the efficacy of mTOR pathway therapeutic agent Everolimus in breast cancer models
por: Kuo, Chun-Ting, et al.
Publicado: (2019)

Myelination and mTOR
por: Figlia, Gianluca, et al.
Publicado: (2017)

Cancer and mTOR inhibitors in kidney transplantation recipients
por: Kao, Chih-Chin, et al.
Publicado: (2018)

mTOR signaling: implications for cancer and anticancer therapy
por: Petroulakis, E, et al.
Publicado: (2006)

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
por: Zou, Zhilin, et al.
Publicado: (2020)

Expression of mTOR/70S6K signaling pathway in pathological scar fibroblasts and the effects of resveratrol intervention
por: Tang, Zhi-Ming, et al.
Publicado: (2017)

Radiofrequency ablation in combination with an mTOR inhibitor restrains pancreatic cancer growth induced by intrinsic HSP70
por: Gao, Shanshan, et al.
Publicado: (2020)

mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting Therapy
por: Tian, Tian, et al.
Publicado: (2019)

Regulation of Osteoclast Growth and Fusion by mTOR/raptor and mTOR/rictor/Akt
por: Tiedemann, Kerstin, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_qsh9av48sbm4241e99ad6qantq